Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)

Adult Blood Glucose Adolescent type 1 diabetes Sustainable Development Goals Diabetes Mellitus, Type 1/drug therapy 610 physical activity 610 Medicine & health Position statement Glycemic Control Adolescents 796 03 medical and health sciences 0302 clinical medicine children Exercise/physiology adults Adults Humans Hypoglycemic Agents Insulin adolescents Child Children Continuous glucose monitoring Exercise Quality Of Life SDG 3 Blood Glucose/metabolism exercise CGM Physical activity Blood Glucose Self-Monitoring position statement Diabetes Mellitus, Type 1/physiopathology Hypoglycemic Agents/administration & dosage 3. Good health Type 1 diabetes Diabetes Mellitus, Type 1 quality of life Ispad Guidelines Quality of Life continuous glucose monitoring Glycemic Control/methods Insulin/administration & dosage
DOI: 10.1007/s00125-020-05263-9 Publication Date: 2020-10-12T23:02:51Z
ABSTRACT
Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and duration of the type of exercise. Understandably, fear of hypoglycaemia is one of the strongest barriers to incorporating exercise into daily life. Risk of hypoglycaemia during and after exercise can be lowered when insulin-dose adjustments are made and/or additional carbohydrates are consumed. Glycaemic management during exercise has been made easier with continuous glucose monitoring (CGM) and intermittently scanned continuous glucose monitoring (isCGM) systems; however, because of the complexity of CGM and isCGM systems, both individuals with type 1 diabetes and their healthcare professionals may struggle with the interpretation of given information to maximise the technological potential for effective use around exercise (ie, before, during and after). This position statement highlights the recent advancements in CGM and isCGM technology, with a focus on the evidence base for their efficacy to sense glucose around exercise and adaptations in the use of these emerging tools, and updates the guidance for exercise in adults, children and adolescents with type 1 diabetes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (106)
CITATIONS (130)